Written Statement to the First Selectman’s Capital Improvement Program’s Public Hearing Regarding Dangers of Artificial Turf

January 9, 2020. Officials in communities all over the country have been misled by artificial turf salespeople. They were erroneously told that these products are safe. But on the contrary, there is clear scientific evidence that these materials are potentially harmful. The only question is how harmful and how much exposure is likely to be harmful? We should not be willing to take such a risk. Our children deserve better.

Read More »

NCHR Comments on FDA’s Draft Guidance on Post-Market Studies and Clinical Trials

December 20, 2019. Post-market clinical trials and other studies can help inform FDA and the public about the risks and benefits of medical products.  However, when they are relied upon to answer questions better addressed prior to approval, or if less effective studies or trials are used, or if studies are delayed and inadequate, they do not provide the intended data that is needed by FDA, patients, and healthcare providers.  This adds to the already high cost of medical care.

Read More »